The project will contribute to improving the conditions for research- and needs-driven innovation in the Life Science area in the Stockholm region. The companies in Life Science have great challenges with the perseverance required to reach the market. Extensive medical evidence and complex regulatory frameworks are required to prove efficacy in treatment and ensure patient safety. Innovation support is fragmented and therefore not equipped to meet business challenges. The innovation support organisations KI Innovations and STING will therefore collaborate to create offers to companies that have passed the incubation phase but have not yet established themselves on the market. In addition, Karolinska University Hospital participates with the aim of becoming an engine for the development and market validation of tomorrow's medical innovations. Together, the parties form a "Circle of Life Science" to support innovative organizations and individuals in the Stockholm region. .